Crossmark

From authorisation to clinical practice: evolution of the use of biological medicines according to the SmPC and guidelines (2006 to 2025)

Crossref DOI link: https://doi.org/10.1007/s00228-026-04097-5

Published Online: 2026-06-10

Published Print: 2026-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Penninx, B. M. F. https://orcid.org/0009-0007-1617-2789
Hollak, C. E. M. https://orcid.org/0000-0003-0464-1078
Tas, S. W. https://orcid.org/0000-0002-8940-1788
Timmers, L. https://orcid.org/0000-0002-9342-814X
de Visser, S. J. https://orcid.org/0000-0003-3649-5714
van Kempen, Z. L. E. https://orcid.org/0000-0001-9557-5381
License Information

Text and Data Mining valid from 2026-06-10

Version of Record valid from 2026-06-10
More Information

Article History

Received: 5 March 2026

Accepted: 2 June 2026

First Online: 10 June 2026

Declarations

:

: Not applicable.

: The authors declare no competing interests.